Literature DB >> 17889430

Successful treatment of relapsing neuro-Sweet's disease with corticosteroid and dapsone combination therapy.

Jiro Fukae1, Kazuyuki Noda, Kenji Fujishima, Ryo Wada, Takashi Yoshiike, Nobutaka Hattori, Yasuyuki Okuma.   

Abstract

Sweet's disease with central nervous system involvement, tentatively named neuro-Sweet's disease, has rarely been reported. Although systemic corticosteroid therapy is highly effective for neurologic symptoms in neuro-Sweet's disease, relapse is common. Here, we describe the case of a 38-year-old Japanese man who presented with relapsing neuro-Sweet's disease that was successfully treated with a combination of corticosteroid and dapsone. Dapsone should be considered as a therapeutic option for neuro-Sweet's disease patients showing relapse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889430     DOI: 10.1016/j.clineuro.2007.07.025

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Sweet syndrome secondary to inflammatory bowel disease.

Authors:  Malcolm M Wells; William Stecho; Bret Wehrli; Nitin Khanna
Journal:  Can J Gastroenterol       Date:  2013-03       Impact factor: 3.522

2.  Protective Effects of Dapsone on Scopolamine-Induced Memory Impairment in Mice: Involvement of Nitric Oxide Pathway.

Authors:  Nafise Noroozi; Maryam Shayan; Adeleh Maleki; Faezeh Eslami; Nastaran Rahimi; Robab Zakeri; Zohreh Abdolmaleki; Ahmad Reza Dehpour
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2022-03-24

3.  Two cases of possible neuro-Sweet disease with meningoencephalitis as the initial manifestation.

Authors:  Go Makimoto; Yasuhiro Manabe; Chizuru Yamakawa; Daiki Fujii; Yasuko Ikeda-Sakai; Hisashi Narai; Nobuhiko Omori; Koji Abe
Journal:  Neurol Int       Date:  2012-02-09

4.  Recurrent Neurological Episodes for 10 Years Preceding Skin Lesions in Neuro-Sweet Disease.

Authors:  Akiyuki Hiraga; Daisuke Ozaki; Makiko Oikawa; Nobuyuki Araki; Satoshi Kuwabara
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

5.  Neuro-Sweet disease with positive modified acid-fast staining of the cerebrospinal fluid: A case report.

Authors:  Juan-Fang Liu; Yuan Li; Kai Li; Xiao Zhang; Yi-Ning Yang; Gang Zhao; Zhi-Rong Liu
Journal:  Exp Ther Med       Date:  2016-02-08       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.